Cardioplegia Solution Recalled Due to Sterility Assurance Concerns
Central Admixture Pharmacy Services, Inc. is recalling cardioplegia solution for lack of assurance of sterility. FDA inspection questioned the sterility of this injectable product; 241 bags were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall concerns a sterile injectable product used in cardiac surgery. While no illnesses or injuries have been reported, the lack of sterility assurance in an injectable surgical product represents a high-risk scenario with potential for serious harm. The score reflects a high-risk product where injury has not yet been reported.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling cardioplegia solution (Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM BICARBONATE, 106 mEq K) in 1000 mL bags due to lack of assurance of sterility.
The recall was initiated after an FDA inspection called into question whether this sterile injectable product met required sterility standards. Cardioplegia solution is an injectable fluid used during cardiac surgery to protect the heart. If sterility cannot be assured, the product poses a potential risk of infection to patients undergoing cardiac procedures.
The recalled product includes 241 bags distributed nationwide. Affected lot numbers are: 37-894705 (Exp 04/30/2023), 37-896127 (Exp 05/06/2023), 37-898278 (Exp 05/14/2023), 37-899148 (Exp 05/19/2023), and 37-900619 (Exp 05/25/2023).
Healthcare providers who received this product should discontinue use of the affected lots and consult with their physician or pharmacist regarding appropriate action. Patients who have received this product during cardiac surgery should consult with their healthcare provider if they have concerns.
The recalled product
- Product
- Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM BICARBONATE, 106 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0204-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug
- Hazard
- sterility-assurance
- injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 37-894705
- Exp 04/30/2023
- 37-896127
- Exp 05/06/2023
- 37-898278
- Exp 05/14/2023
- 37-899148
- Exp 05/19/2023
- 37-900619
- Exp 05/25/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27